Topics

Today, we announced a new collaboration with @benevolent_ai to use #ArtificialIntelligence and #MachineLearning to discover potential new treatments for chronic kidney disease and idiopathic pulmonary fibrosis. Find out more: http://bit.ly/2VyOyA5 pic.t

03:54 EDT 30 Apr 2019 | AztraZeneca

Today, we announced a new collaboration with to use and to discover potential new treatments for chronic kidney disease and idiopathic pulmonary fibrosis. Find out more: http://bit.ly/2VyOyA5 

Original Article: Today, we announced a new collaboration with @benevolent_ai to use #ArtificialIntelligence and #MachineLearning to discover potential new treatments for chronic kidney disease and idiopathic pulmonary fibrosis. Find out more: http://bit.ly/2VyOyA5 pic.t

NEXT ARTICLE

More From BioPortfolio on "Today, we announced a new collaboration with @benevolent_ai to use #ArtificialIntelligence and #MachineLearning to discover potential new treatments for chronic kidney disease and idiopathic pulmonary fibrosis. Find out more: http://bit.ly/2VyOyA5 pic.t"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...